Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nls Pharmaceutics Ltd (NQ: NLSP ) 4.875 UNCHANGED Streaming Delayed Price Updated: 3:34 PM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nls Pharmaceutics Ltd < Previous 1 2 3 4 5 6 7 Next > 25 Stocks Moving in Monday's Pre-Market Session February 14, 2022 Gainers Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 52.8% to $0.65 in pre-market trading after declining 6% on Friday. TC BioPharm (Holdings) plc (NASDAQ: TCBP)... Via Benzinga NLS Pharmaceutics to Participate in 2022 BIO CEO & Investor Conference February 11, 2022 ZURICH, SWITZERLAND / ACCESSWIRE / February 11, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the... From NLS Pharmaceutics AG Via AccessWire Why Are NLS Pharmaceutics Shares Trading Higher During Premarket Monday? February 07, 2022 NLS Pharmaceutics Ltd (NASDAQ: NLSP) shares are trading higher after the Company announced to present interim topline data from its Phase 2a trial evaluating its lead product candidate, Quilience... Via Benzinga NLS Pharmaceutics to Present Interim Top-Line Data for Quilience(R) (Mazindol ER) in Patients with Narcolepsy at the World Sleep Congress in March 2022 February 07, 2022 - Phase 2a trial meets enrollment target for interim analysis and is now more than 50% enrolled - 21 clinical sites in the United States actively enrolling patients - Nearly 90% of patients completing... From NLS Pharmaceutics AG Via AccessWire 47 Biggest Movers From Yesterday February 08, 2022 Gainers Nuvectis Pharma, Inc. (NASDAQ: NVCT) shares surged 144.6% to close at $7.95 on Monday. The company, on Friday, priced its IPO at $5 per share. Anghami Inc. (NASDAQ: ANGH... Via Benzinga NLS Pharmaceutics Invites Patients, Caregivers and Other Interested Parties to Attend International Narcolepsy Webinar January 12, 2022 ZURICH, SWITZERLAND / ACCESSWIRE / January 12, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and... From NLS Pharmaceutics AG Via AccessWire 58 Biggest Movers From Yesterday January 07, 2022 Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-... Via Benzinga 33 Stocks Moving In Thursday's Mid-Day Session January 06, 2022 Gainers Eargo, Inc. (NASDAQ: EAR) shares jumped 50.8% to $6.88 after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday January 06, 2022 Good morning, trader! Let's start off the day right with a look into some of the biggest pre-market stock movers for Thursday! Via InvestorPlace 23 Stocks Moving in Thursday's Pre-Market Session January 06, 2022 Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 54.3% to $0.9490 in pre-market trading after declining more than 11% on Wednesday. Alterity Therapeutics Limited... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday January 05, 2022 Good morning, trader! It's time for another busy day of trading with a look at the biggest pre-market stock movers for Wednesday! Via InvestorPlace 45 Biggest Movers From Yesterday January 05, 2022 Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced... Via Benzinga NLS Pharmaceutics Announces Patent Issuance in the United States for its Mazindol Extended-Release Formulation January 04, 2022 - Key patent now granted in major markets including the U.S., Europe, Canada & South Korea - Patent claims cover use of the Company's lead product candidate, Quilience® (mazindol ER) in both attention... From NLS Pharmaceutics AG Via AccessWire Topics Intellectual Property Exposures Intellectual Property 18 Stocks Moving in Monday's Pre-Market Session January 03, 2022 Gainers Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) rose 41.6% to $3.13 in pre-market trading after gaining around 8% on Friday. Armstrong Flooring, Inc. (NYSE: AFI... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday December 06, 2021 Welcome back, trader! We're starting off another busy week with a look at the biggest pre-market stock movers for Monday! Via InvestorPlace 40 Stocks Moving In Thursday's Mid-Day Session December 02, 2021 Gainers Biofrontera Inc. (NASDAQ: BFRI) surged 39% to $6.02. Biofrontera announced Notice of Allowance for U.S. patent titled 'Illumination for Photodynamic Therapy.'... Via Benzinga Topics Intellectual Property Exposures Intellectual Property 61 Biggest Movers From Yesterday December 03, 2021 Gainers Jowell Global Ltd. (NASDAQ: JWEL) jumped 25.5% to close at $13.36. Jowell Global recently announced a collaboration with Unilever's Uni-Excubator. Information... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday December 02, 2021 Good morning, trader! We're gearing up for another busy day of trading with the biggest pre-market stock movers for Thursday! Via InvestorPlace 27 Stocks Moving in Thursday's Pre-Market Session December 02, 2021 Gainers Phunware, Inc. (NASDAQ: PHUN) rose 25.8% to $4.09 in pre-market trading after surging around 12% on Wednesday. Digital World Acquisition Corp. (NASDAQ: DWAC)... Via Benzinga 50 Stocks Moving In Wednesday's Mid-Day Session December 01, 2021 Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) climbed 91.7% to $6.14 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down Moderna's... Via Benzinga Topics Intellectual Property Exposures Intellectual Property Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday December 01, 2021 Good morning, traders! We're starting off the day right with a look at the biggest pre-market stock movers for Wednesday! Via InvestorPlace 23 Stocks Moving in Wednesday's Pre-Market Session December 01, 2021 Gainers Skylight Health Group Inc. (NASDAQ: SLHG) rose 55.3% to $2.05 in pre-market trading after dipping around 10% on Tuesday. Skylight Health Group, last month, posted a... Via Benzinga NLS Pharmaceutics Announces Preclinical Results Confirming the Potential Benefit and Safety Profile of NLS-4 for Circadian Rhythm Dysregulation and Chronic Fatigue Syndrome in Long-Covid Model November 30, 2021 STANS, SWITZERLAND / ACCESSWIRE / November 30, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and... From NLS Pharmaceutics AG Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal NLS Pharmaceutics CEO Issues Letter to Shareholders November 01, 2021 STANS, SWITZERLAND / ACCESSWIRE / November 1, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the... From NLS Pharmaceutics AG Via AccessWire Topics Initial Public Offering Intellectual Property Regulatory Compliance Exposures Intellectual Property Legal Regulatory Leading the Charge to Develop the First Orexin-Targeted Therapy to Address Narcolepsy at its Root Cause October 20, 2021 Photo by MART PRODUCTION from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... Via Benzinga NLS Pharmaceutics Announces Preclinical Data Demonstrating the Potential of NLS-4 (Lauflumide) to Treat Chronic Fatigue Associated With Long-COVID October 14, 2021 STANS, SWITZERLAND / ACCESSWIRE / October 14, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and... From NLS Pharmaceutics AG Via AccessWire Topics Intellectual Property Product Recall Regulatory Compliance Exposures COVID-19 Intellectual Property Legal 36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021 October 04, 2021 RALEIGH, NC / ACCESSWIRE / October 4, 2021 / The Fall Harvest - Best Ideas from the Buy-Side will take place on October 5th - 8th, 2021, where 36 SmallCap, MicroCap and NanoCap public companies will be... From MicroCap Rodeo Via AccessWire NLS Pharmaceutics to Participate in The Micro Cap Rodeo Fall Harvest Conference: Best Ideas from the Buy-side September 30, 2021 STANS, SWITZERLAND / ACCESSWIRE / September 30, 2021 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and... From NLS Pharmaceutics AG Via AccessWire NLS Pharmaceutics Announces $20 Million Standby Equity Distribution Agreement and $2.5 Million Equity Investment September 28, 2021 STANS, SWITZERLAND / ACCESSWIRE / September 28, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery... From NLS Pharmaceutics AG Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures Intellectual Property Legal Regulatory NLS Pharmaceutics to Participate in the Benzinga Healthcare Small Cap Conference September 24, 2021 STANS, SWITZERLAND / ACCESSWIRE / September 24, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the... From NLS Pharmaceutics AG Via AccessWire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.